Total Company Value: Celcuity Therapeutics (CELC)
High-precision robots and AI determine the reaction of living cells to treatment, although the final verdict remains with the physicians. Celcuity Inc. (CELC) balances a narrow specialization in diagnostic platforms with the development of its own oncology drugs. CELx technologies automate the analysis of signaling pathways, eliminating human error. This chart from GURU.Markets captures the Enterprise Value at 3331.14.
&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_CELC_-_Celcuity-Inc._-_Enterprise-Value "CELC (celcuity.com) Real Price to Acquire Entire Company history from 11/23/2025 to 10/28/2026 | 👁️GURU.Markets👁️")
CELC (Celcuity Inc.): analytical breakdowns and indicator data
The dynamics of this metric reflect the operational efficiency of capital management, where the final business value is determined by the sum of market capitalization and net debt. For Celcuity Inc. (CELC), which is expanding its network of clinical partnerships in the US, such a valuation demonstrates the actual cost of asset acquisition, which is clearly evidenced through the enterprise value.